{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:46:57Z","timestamp":1793710017018,"version":"4.6.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.cellsig.2025.112034","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:56:07Z","timestamp":1754434567000},"page":"112034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["RRM2-mediated inhibition of GPX4 ubiquitination: A novel mechanism for ferroptosis suppression and reduced cisplatin sensitivity in small cell lung cancer"],"prefix":"10.1016","volume":"135","author":[{"given":"Lijie","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiong","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobin","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengzhou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moufeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellsig.2025.112034_bb0005","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112034_bb0010","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jtho.2016.01.012","article-title":"Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?","volume":"11","author":"Bunn","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112034_bb0015","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrc.2017.87","article-title":"Small-cell lung cancer: what we know, what we need to know and the path forward","volume":"17","author":"Gazdar","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2025.112034_bb0020","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.eclinm.2024.102795","article-title":"Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small\u2013cell lung cancer (ES-SCLC): a phase II trial","volume":"75","author":"Chen","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"12","key":"10.1016\/j.cellsig.2025.112034_bb0025","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jtho.2021.07.018","article-title":"Overcoming chemotherapy resistance in SCLC","volume":"16","author":"Herzog","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.cellsig.2025.112034_bb0030","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.ejca.2024.113581","article-title":"Recent advances and future strategies in first-line treatment of ES-SCLC","volume":"200","author":"Gomez-Randulfe","year":"2024","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112034_bb0035","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.cellsig.2025.112034_bb0040","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1007\/s00018-023-04907-4","article-title":"Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance","volume":"80","author":"Ren","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.cellsig.2025.112034_bb0045","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.tcb.2023.04.005","article-title":"Ferroptosis: mechanisms and implications for cancer development and therapy response","volume":"33","author":"dos Santos","year":"2023","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112034_bb0050","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"2014","author":"Dixon","year":"2014","journal-title":"Elife"},{"issue":"559","key":"10.1016\/j.cellsig.2025.112034_bb0055","article-title":"Targeting GPX4 in human cancer: implications of ferroptosis induction for tackling cancer resilience","volume":"2023","author":"Lee","year":"2023","journal-title":"Cancer Lett."},{"issue":"7664","key":"10.1016\/j.cellsig.2025.112034_bb0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112034_bb0065","first-page":"2023","article-title":"Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"14","key":"10.1016\/j.cellsig.2025.112034_bb0070","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1158\/1078-0432.CCR-18-4046","article-title":"A novel mechanism driving poor-prognosis prostate Cancer: overexpression of the DNA repair gene, ribonucleotide reductase small subunit M2 (RRM2)","volume":"25","author":"Mazzu","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"38","key":"10.1016\/j.cellsig.2025.112034_bb0075","doi-asserted-by":"crossref","first-page":"10084","DOI":"10.1016\/j.biomaterials.2013.08.088","article-title":"Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA","volume":"34","author":"Gao","year":"2013","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.cellsig.2025.112034_bb0080","first-page":"2151","article-title":"Overexpression of catalytic subunit M2 in patients with ovarian cancer","volume":"125","author":"Wang","year":"2012","journal-title":"Chin. Med. J."},{"issue":"16","key":"10.1016\/j.cellsig.2025.112034_bb0085","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1038\/onc.2014.155","article-title":"Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies","volume":"34","author":"Aye","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2025.112034_bb0090","article-title":"Ribonucleotide reductase M2 (RRM2): regulation, function and targeting strategy in human cancer","volume":"2022","author":"Zuo","year":"2022","journal-title":"Genes & Diseases"},{"issue":"3","key":"10.1016\/j.cellsig.2025.112034_bb0095","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7150\/ijbs.30114","article-title":"RRM2 is a potential prognostic biomarker with functional significance in glioma","volume":"15","author":"Sun","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"10","key":"10.1016\/j.cellsig.2025.112034_bb0100","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1002\/jcp.26529","article-title":"RRM2 promotes the progression of human glioblastoma","volume":"233","author":"Li","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112034_bb0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s13578-021-00586-5","article-title":"RRM2 silencing suppresses malignant phenotype and enhances radiosensitivity via activating cGAS\/STING signaling pathway in lung adenocarcinoma","volume":"11","author":"Jiang","year":"2021","journal-title":"Cell Biosci."},{"issue":"3","key":"10.1016\/j.cellsig.2025.112034_bb0110","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1007\/s13277-013-1255-4","article-title":"Expression of RRM1 and RRM2 as a novel prognostic marker in advanced non-small cell lung cancer receiving chemotherapy","volume":"35","author":"Wang","year":"2014","journal-title":"Tumour Biol."},{"issue":"22","key":"10.1016\/j.cellsig.2025.112034_bb0115","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.18632\/aging.204385","article-title":"Development and validation of a novel model for predicting the survival of bladder cancer based on ferroptosis-related genes","volume":"14","author":"Li","year":"2022","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112034_bb0120","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1186\/s12935-022-02699-4","article-title":"Identification and validation of a ferroptosis-related gene to predict survival outcomes and the immune microenvironment in lung adenocarcinoma","volume":"22","author":"Deng","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112034_bb0125","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.tips.2024.05.006","article-title":"Targeting GPX4 in ferroptosis and cancer: chemical strategies and challenges","volume":"45","author":"Liu","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112034_bb0130","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s41418-020-00728-1","article-title":"Cellular degradation systems in ferroptosis","volume":"28","author":"Chen","year":"2021","journal-title":"Cell Death Differ."},{"issue":"133","key":"10.1016\/j.cellsig.2025.112034_bb0135","article-title":"Inhibiting RRM2 to enhance the anticancer activity of chemotherapy","volume":"2021","author":"Zhan","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"28","key":"10.1016\/j.cellsig.2025.112034_bb0140","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn1382","article-title":"RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition","volume":"8","author":"Nunes","year":"2022","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112034_bb0145","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1186\/s13000-021-01174-4","article-title":"RRM2 expression in different molecular subtypes of breast cancer and its prognostic significance","volume":"17","author":"Abdel-Rahman","year":"2022","journal-title":"Diagn. Pathol."},{"issue":"6","key":"10.1016\/j.cellsig.2025.112034_bb0150","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1365-2559.2010.03725.x","article-title":"Ribonucleotide reductase M2 subunit is a novel diagnostic marker and a potential therapeutic target in bladder cancer","volume":"57","author":"Morikawa","year":"2010","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.cellsig.2025.112034_bb0155","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.26508\/lsa.202101157","article-title":"Nucleotide biosynthesis links glutathione metabolism to ferroptosis sensitivity","volume":"5","author":"Tarangelo","year":"2022","journal-title":"Life Science Alliance"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112034_bb0160","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/s12935-020-01689-8","article-title":"RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer","volume":"20","author":"Yang","year":"2020","journal-title":"Cancer Cell Int."},{"issue":"8","key":"10.1016\/j.cellsig.2025.112034_bb0165","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41594-024-01329-z","article-title":"PRDX6 augments selenium utilization to limit iron toxicity and ferroptosis","volume":"31","author":"Fujita","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"23","key":"10.1016\/j.cellsig.2025.112034_bb0170","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1016\/j.molcel.2024.10.028","article-title":"PRDX6 dictates ferroptosis sensitivity by directing cellular selenium utilization","volume":"84","author":"Ito","year":"2024","journal-title":"Mol. Cell"},{"issue":"13","key":"10.1016\/j.cellsig.2025.112034_bb0175","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","article-title":"Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones","volume":"186","author":"Liang","year":"2023","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.cellsig.2025.112034_bb0180","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1080\/15548627.2023.2218764","article-title":"GPX4 in cell death, autophagy, and disease","volume":"19","author":"Xie","year":"2023","journal-title":"Autophagy"},{"issue":"7","key":"10.1016\/j.cellsig.2025.112034_bb0185","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion","volume":"19","author":"Friedmann Angeli","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2025.112034_bb0190","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.drup.2022.100916","article-title":"Overcoming cancer chemotherapy resistance by the induction of ferroptosis","volume":"66","author":"Wang","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"4","key":"10.1016\/j.cellsig.2025.112034_bb0195","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","article-title":"The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions","volume":"42","author":"Lei","year":"2024","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.cellsig.2025.112034_bb0200","first-page":"2024","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.cellsig.2025.112034_bb0205","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41392-023-01606-1","article-title":"Targeting ferroptosis opens new avenues for the development of novel therapeutics","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"68","key":"10.1016\/j.cellsig.2025.112034_bb0210","article-title":"Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs","volume":"2023","author":"Qi","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"68","key":"10.1016\/j.cellsig.2025.112034_bb0215","article-title":"RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer","volume":"2023","author":"Xu","year":"2023","journal-title":"Redox Biol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825004498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656825004498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T15:19:46Z","timestamp":1772810386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656825004498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":43,"alternative-id":["S0898656825004498"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112034","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RRM2-mediated inhibition of GPX4 ubiquitination: A novel mechanism for ferroptosis suppression and reduced cisplatin sensitivity in small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2025.112034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112034"}}